LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microfluidic Disposable Device Diagnoses Diseases Cheaply

By LabMedica International staff writers
Posted on 16 Dec 2015
Print article
Image: Schematics of the reusable acoustic tweezers device (bottom) with a disposable microfluidic laboratory for cell manipulation and disease diagnosis (Photo courtesy of Penn State University).
Image: Schematics of the reusable acoustic tweezers device (bottom) with a disposable microfluidic laboratory for cell manipulation and disease diagnosis (Photo courtesy of Penn State University).
The development of a reusable microfluidic device for sorting and manipulating cells and other micro/nano meter scale objects will make biomedical diagnosis of diseases cheaper and more convenient in regions where medical facilities are sparse or cost is prohibitive.

Both bulk acoustic wave (BAW) and surface acoustic wave (SAW) based approaches have shown their competency in the manipulation of macro- to nano- scale objects, regardless of an object's optical or electrical properties. A wide range of applications in static or continuous flow such as manipulating cells, moving organisms have been demonstrated by either BAW or SAW tweezers.

Scientists at the Penn State University (University Park, PA, USA) developed reusable acoustic tweezers to realize acoustic manipulation of cells or particles with a SAW platform and disposable superstrate devices. They locally transmitted standing surface acoustic waves into a removable, independent polydimethylsiloxane (PDMS)-glass hybridized microfluidic superstrate device for micromanipulation. By configuring and regulating the displacement nodes on a piezoelectric substrate, cells and particles were effectively patterned and transported into the superstrate.

The label-free and contactless nature of acoustic waves could offer a simple, accurate, low-cost, biocompatible, and disposable method for applications in the fields of point-of-care diagnostics and fundamental biomedical studies. In addition to its use in diagnosing diseases such as human immunodeficiency virus (HIV) and tuberculosis, both of which are endemic in resource-poor regions of the world, the device should find widespread use in hospitals, clinics, biology laboratories and the home due to its low cost and ease of use.

Tony Jun Huang, PhD, a professor and lead author of the study, said, “We believe our acoustic tweezers have tremendous potential, especially in diagnostics, with some applications also in therapeutics. Our current device works well, but to be used in diagnostics, the whole device has to be disposed of after one use. We have now found a way to separate the fluid-containing part of the device from the much more expensive ultrasound-producing piezoelectric substrate. This makes disposable acoustic tweezers possible.” The study was published on October 28, 2015, in the journal Lab on a Chip.

Related Links:

Penn State University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more